Compare PALI & CMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PALI | CMRC |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United States |
| Employees | N/A | 1611 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.2M | 229.2M |
| IPO Year | 2019 | N/A |
| Metric | PALI | CMRC |
|---|---|---|
| Price | $1.63 | $2.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $13.00 | $5.50 |
| AVG Volume (30 Days) | ★ 3.0M | 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | $5.41 |
| Revenue Next Year | N/A | $4.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $2.41 |
| 52 Week High | $2.64 | $5.55 |
| Indicator | PALI | CMRC |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 47.61 |
| Support Level | $1.57 | $2.41 |
| Resistance Level | $1.93 | $3.45 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 16.22 | 38.96 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Commerce.com Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of its revenue is generated from Americas-U.S.